Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Celerion
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Androxal (Enclomiphene Citrate) is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hypogonadism.
Product Name : Androxal
Product Type : Hormone
Upfront Cash : Inapplicable
October 24, 2014
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Celerion
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
Details : Enclomiphene Citrate is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
June 23, 2014
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal
Details : Androxal is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 23, 2014
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
Details : Androxal is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 21, 2014
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Enclomiphene Citrate is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypogonadism.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
November 25, 2013
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Androxal (Enclomiphene Citrate) is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Hypogonadism.
Product Name : Androxal
Product Type : Hormone
Upfront Cash : Inapplicable
November 25, 2013
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males
Details : Enclomiphene Citrate is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
November 25, 2013
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison of Two Formulations of Androxal
Details : Androxal is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 14, 2013
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
Details : Enclomiphene Citrate is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 10, 2013
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Androxal (Enclomiphene Citrate) is a Hormone drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hypogonadism.
Product Name : Androxal
Product Type : Hormone
Upfront Cash : Inapplicable
August 16, 2013
Lead Product(s) : Clomiphene Citrate
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
